How can I write a prescription for hydromorphone (Hydromorphone Contin) 3 mg capsules, dosing 2 capsules twice daily, to dispense a 30‑day supply instead of every 14 days?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Prescription Writing for Monthly Hydromorphone Contin Dispensing

To convert your hydromorphone prescription from 14-day to 30-day dispensing, write: "Hydromorphone Contin 3 mg capsules, take 2 capsules by mouth twice daily, dispense 120 capsules (30-day supply), no refills" and ensure you comply with your jurisdiction's controlled substance prescribing regulations.

Prescription Components

Your current regimen is:

  • Dose per administration: 2 capsules × 3 mg = 6 mg
  • Frequency: Twice daily (BID)
  • Daily total: 12 mg hydromorphone
  • 14-day supply: 56 capsules (2 caps × 2 times/day × 14 days)
  • 30-day supply: 120 capsules (2 caps × 2 times/day × 30 days)

Exact Prescription Format

Write the prescription as follows:

Hydromorphone Contin 3 mg capsules
Sig: Take 2 capsules by mouth twice daily
Quantity: 120 capsules
Days supply: 30 days
Refills: 0 (or as appropriate per your jurisdiction)

Critical Dosing Context

This regimen represents 60 MME/day (12 mg hydromorphone × 5.0 conversion factor = 60 MME) 1. The 2022 CDC guidelines emphasize that dosages ≥50 MME/day require careful reassessment of individual benefits and risks, as many patients do not experience additional benefit in pain or function from increasing opioid dosages to this level but face progressive increases in risk 1.

Key Prescribing Considerations

Regulatory compliance:

  • Most jurisdictions require controlled substance prescriptions to specify exact quantity and days supply
  • Some states mandate electronic prescribing for Schedule II opioids
  • Verify your state's maximum days supply allowed per prescription (some limit to 30 days for chronic pain)

Clinical monitoring at this dose level:

  • Before prescribing at 60 MME/day, document individualized assessment of benefits versus risks 1
  • The 2022 CDC guidelines recommend pausing and carefully reassessing when at or above 50 MME/day 1
  • Consider naloxone co-prescribing at this dosage threshold

Common Pitfalls to Avoid

  • Don't write "as needed" or PRN for chronic pain management; around-the-clock dosing is appropriate for continuous pain 2
  • Don't forget to specify "no refills" on the initial prescription; controlled substances typically require new prescriptions
  • Don't use abbreviations like "BID" in the patient directions on the actual prescription label (write "twice daily")
  • Ensure the quantity matches the days supply calculation to avoid pharmacy dispensing errors or insurance rejections

References

Related Questions

What is the appropriate repeat prescription (quantity and schedule) for a patient on controlled‑release hydromorphone 3 mg twice daily, including the recommended immediate‑release rescue dose?
What is the dispensing rule for hydromorphone Contin (hydromorphone) 3 mg twice daily—should a 30‑day supply of 60 tablets be provided each month?
What is an appropriate taper schedule for a patient on hydromorphone controlled-release 12 mg twice daily?
What are the dosing and monitoring recommendations for hydromorphone 2 mg IV push every two hours as needed in a hospitalized adult patient?
What is the optimal adjustment to the patient's hydromorphone regimen for consistent pain control?
What is the clinical significance of polyuria in a patient with benign prostatic hyperplasia and how should it be evaluated and managed?
Can I use table salt as an alternative to sodium chloride tablets to increase serum sodium in a 70-year-old male patient who cannot tolerate sodium chloride tablets?
How does obstructive sleep apnea (OSA) affect nocturia in an older man with benign prostatic hyperplasia (BPH)?
How do I write a prescription with a 'do not fill before' date for a patient who has already started therapy, using a single 30‑day script or two sequential 14‑day scripts?
When should midazolam (Versed) be administered during rapid‑sequence intubation and airway management?
What prophylactic regimen should be administered to prevent opportunistic infections in a liver transplant recipient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.